Search News

Corporate Industry Technology Medical Updates

cardiogenic shock

Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022 2022-09-09
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Technology
Latest on China-made ECMO: Beijing Anzhen Hospital, magAssist partner on ECMO R&D project 2022-03-24
Corporate
magAssist was awarded the title of "Venture 100 Future Unicorn" 2021-12-17
Medical Updates
Percutaneous Ventricular Assist Device jointly developed by Ge Junbo’s team of Zhongshan Hospital affiliated to Fudan university and magAssist has made ground-breaking achievements 2021-07-17
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16
Medical Updates
Big country Great Medic｜Nianguo Dong's team, pioneer of heart transplantation in China 2021-06-09
Medical Updates
Zhongshan Hospital and magAssist Percutaneous Ventricular Assist Device Cooperation Kick-off Meeting Successfully Held 2020-09-07
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,